ROSALIND ADVISORS, INC.

PrivateCIK: 1622627
πŸ“‹ What this filing means

ROSALIND ADVISORS, INC. filed this quarterly 13F‑HR report disclosing 39 equity positions with a total reported market value of $292.56M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

39
Positions
$292.56M
Total AUM (reported)
51M
Total Shares

Allocation by class

TOTAL AUM$292.56M39 positions
COM NEW$140.60M48.1%
COM$110.91M37.9%
SHS NEW$13.50M4.6%
SPONSORED ADS$10.67M3.6%
PUT$7.72M2.6%
SHS$7.30M2.5%
CALL$1.86M0.6%

Portfolio Concentration

Top 325.4%4–1034.7%11–2535.7%Rest4.2%TOP 1060.1%0%100%
Top 3$74.43M25.4%
4–10$101.45M34.7%
11–25$104.46M35.7%
Rest$12.22M4.2%

Top 3 weight

25.4%

Top 10 weight

60.1%

Voting Authority Distribution

Total shares with voting rights: 51M

Sole

Full voting authority

51M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole39
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings39
Rows:

DELCATH SYS INC

SOLE
COM NEW
Shares3.30M
TypeSH
Market value$33.00M
11.28%
Sole
3.30M
Shared
0.00
None
0.00

CYTOKINETICS INC

SOLE
COM NEW
Shares400K
TypeSH
Market value$21.98M
7.51%
Sole
400K
Shared
0.00
None
0.00

FENNEC PHARMACEUTICALS INC

SOLE
COM
Shares2.08M
TypeSH
Market value$19.44M
6.64%
Sole
2.08M
Shared
0.00
None
0.00

VERASTEM INC

SOLE
COM NEW
Shares1.93M
TypeSH
Market value$17.04M
5.82%
Sole
1.93M
Shared
0.00
None
0.00

REZOLUTE INC

SOLE
COM NEW
Shares1.81M
TypeSH
Market value$16.99M
5.81%
Sole
1.81M
Shared
0.00
None
0.00

XERIS BIOPHARMA HOLDINGS INC

SOLE
COM
Shares1.80M
TypeSH
Market value$14.62M
5.00%
Sole
1.80M
Shared
0.00
None
0.00

SAVARA INC

SOLE
COM
Shares4M
TypeSH
Market value$14.28M
4.88%
Sole
4M
Shared
0.00
None
0.00

MEDIWOUND LTD

SOLE
SHS NEW
Shares749.05K
TypeSH
Market value$13.50M
4.61%
Sole
749.05K
Shared
0.00
None
0.00

VIRIDIAN THERAPEUTICS INC

SOLE
COM
Shares600K
TypeSH
Market value$12.95M
4.43%
Sole
600K
Shared
0.00
None
0.00

CG ONCOLOGY INC

SOLE
COM
Shares300K
TypeSH
Market value$12.08M
4.13%
Sole
300K
Shared
0.00
None
0.00

VERONA PHARMA PLC

SOLE
SPONSORED ADS
Shares100K
TypeSH
Market value$10.67M
3.65%
Sole
100K
Shared
0.00
None
0.00

IDEAYA BIOSCIENCES INC

SOLE
COM
Shares350K
TypeSH
Market value$9.52M
3.26%
Sole
350K
Shared
0.00
None
0.00

INSPIREMD INC

SOLE
COM
Shares3.91M
TypeSH
Market value$9.41M
3.22%
Sole
3.91M
Shared
0.00
None
0.00

EYEPOINT PHARMACEUTICALS INC

SOLE
COM NEW
Shares650K
TypeSH
Market value$9.26M
3.16%
Sole
650K
Shared
0.00
None
0.00

MIND MEDICINE MINDMED INC

SOLE
COM NEW
Shares750K
TypeSH
Market value$8.84M
3.02%
Sole
750K
Shared
0.00
None
0.00

CYBIN INC

SOLE
COM NEW
Shares1.50M
TypeSH
Market value$8.84M
3.02%
Sole
1.50M
Shared
0.00
None
0.00

FRACTYL HEALTH INC

SOLE
COM
Shares5M
TypeSH
Market value$7.95M
2.72%
Sole
5M
Shared
0.00
None
0.00

ATYR PHARMA INC

SOLE
COM NEW
Shares1.04M
TypeSH
Market value$7.56M
2.59%
Sole
1.04M
Shared
0.00
None
0.00

UNIQURE NV

SOLE
SHS
Shares125K
TypeSH
Market value$7.30M
2.49%
Sole
125K
Shared
0.00
None
0.00

X4 PHARMACEUTICALS INC

SOLE
COM NEW
Shares1.54M
TypeSH
Market value$5.28M
1.81%
Sole
1.54M
Shared
0.00
None
0.00

OCULAR THERAPEUTIX INC

SOLE
COM
Shares400K
TypeSH
Market value$4.68M
1.60%
Sole
400K
Shared
0.00
None
0.00

ATYR PHARMA INC

SOLE
PUT
Shares1.57M
TypeSH
Market value$4.47M
1.53%
Sole
1.57M
Shared
0.00
None
0.00

TALPHERA INC

SOLE
COM NEW
Shares4.39M
TypeSH
Market value$3.92M
1.34%
Sole
4.39M
Shared
0.00
None
0.00

PROFOUND MED CORP

SOLE
COM NEW
Shares692.18K
TypeSH
Market value$3.38M
1.16%
Sole
692.18K
Shared
0.00
None
0.00

MYOMO INC

SOLE
COM NEW
Shares3.79M
TypeSH
Market value$3.38M
1.16%
Sole
3.79M
Shared
0.00
None
0.00
Page 1 of 2
ROSALIND ADVISORS, INC. 13F Holdings β€” 39 Positions | Finecho